Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SmartSignal is a predictive analytics company that provides software solutions for equipment health monitoring and diagnostics, with significant applications in the healthcare and pharmaceutical manufacturing sectors. Originally developed at Argonne National Laboratory, the company's technology utilizes similarity-based modeling to identify subtle changes in equipment behavior that precede failure, allowing for proactive maintenance. In the life sciences, SmartSignal is used for Process Analytical Technology (PAT) to monitor drug manufacturing equipment and for Clinical Asset Performance Management to ensure the reliability of medical imaging devices like MRI and CT scanners. The company was acquired by GE in 2011 and its technology is now a core component of the GE Digital Asset Performance Management (APM) suite.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SmartSignal.